A detailed history of Empirical Finance, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 13,221 shares of DXCM stock, worth $1.48 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,221
Previous 12,642 4.58%
Holding current value
$1.48 Million
Previous $1.18 Million 55.47%
% of portfolio
0.11%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $66,133 - $81,117
579 Added 4.58%
13,221 $1.83 Million
Q3 2023

Nov 02, 2023

BUY
$86.06 - $137.93 $114,717 - $183,860
1,333 Added 11.79%
12,642 $1.18 Million
Q2 2023

Jul 27, 2023

BUY
$112.47 - $130.98 $140,924 - $164,117
1,253 Added 12.46%
11,309 $1.45 Million
Q1 2023

Apr 05, 2023

BUY
$104.0 - $122.92 $62,088 - $73,383
597 Added 6.31%
10,056 $1.17 Million
Q4 2022

Jan 24, 2023

BUY
$84.98 - $122.67 $72,317 - $104,392
851 Added 9.89%
9,459 $1.07 Million
Q3 2022

Nov 04, 2022

BUY
$76.35 - $94.18 $121,167 - $149,463
1,587 Added 22.6%
8,608 $693,000
Q2 2022

Aug 01, 2022

BUY
$67.99 - $132.89 $365,378 - $714,150
5,374 Added 326.29%
7,021 $523,000
Q1 2022

Apr 21, 2022

BUY
$94.08 - $130.2 $35,562 - $49,215
378 Added 29.79%
1,647 $843,000
Q4 2021

Feb 04, 2022

BUY
$129.87 - $162.82 $37,922 - $47,543
292 Added 29.89%
1,269 $681,000
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $8,216 - $11,024
77 Added 8.56%
977 $534,000
Q2 2021

Aug 10, 2021

BUY
$80.99 - $107.93 $12,958 - $17,268
160 Added 21.62%
900 $384,000
Q4 2020

Feb 02, 2021

BUY
$78.0 - $104.5 $13,650 - $18,287
175 Added 30.97%
740 $274,000
Q3 2020

Oct 28, 2020

BUY
$95.51 - $112.95 $53,963 - $63,816
565 New
565 $233,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.